Back to search

Article

MYL2 is a potential diagnostic, prognostic, and immune biomarker for HNSC

2023-09-25

Abstract excerpt

<h4>Purpose: </h4> MYL2, a potential biomarker, is aberrantly expressed in a variety of tumor tissues. The purpose of this study was to determine the exact involvement of MYL2 in HNSC. Methods Massive bioinformatics analysiswere used to assess MYL2 mRNA and protein expression levels and its functional role in HNSC. Next, the prognostic effect of MYL2 on HNSC was analyzed using TCGA and GEPIA. Afterwards, the effe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b0a2d929-4e54-5dbd-a025-face22ae86cd
DOI
10.21203/rs.3.rs-3366357/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MYL2 is a potential diagnostic, prognostic, and immune biomarker for HNSCDOI 10.21203/rs.3.rs-3366357/v1
Select a neighboring publication to make it the new centre.